Effects of raloxifene on voltage-dependent T-type Ca channels in mouse spermatogenic cells

Pharmacology

Volumn 87, Issue 1-2, 2011, Pages 70-80

  Wang, Qiang ^a   Lu, Liang ^b   Gao, Xiaohua ^a   Wang, Changsong ^c   Wang, Jun ^a   Cheng, Jie ^a   Gao, Rong ^a   Xiao, Hang ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b National Shanghai Center for New Drug Safety Evaluation and Research   (China)

^c Wuxi Xihui Center of Disease Control and Prevention of Jiangsu Province   (China)

Author keywords

Patch clamp; Raloxifene; Reverse transcriptase polymerase chain reaction; Spermatogenic cells; Voltage dependent T type Ca2+ channels

Indexed keywords

CALCIUM CHANNEL T TYPE; ESTRADIOL; ESTROGEN; FULVESTRANT; MESSENGER RNA; RALOXIFENE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ELECTROPHYSIOLOGY; IC 50; MALE; MALE GENITAL SYSTEM FUNCTION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SPERMATOCYTE; STEADY STATE;

ACTION POTENTIALS; ANIMALS; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, T-TYPE; CELL LINE; CELLS, CULTURED; DOWN-REGULATION; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGENS, NON-STEROIDAL; KINETICS; MALE; MICE; MICE, INBRED ICR; PATCH-CLAMP TECHNIQUES; RALOXIFENE; RNA, MESSENGER; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SPERMATOCYTES;

EID: 78651241679     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321726     Document Type: Article

References (32)

1. Tsourdi E, Kourtis A, Farmakiotis D, Katsikis I, Salmas M, Panidis D: The effect of selective estrogen receptor modulator administration on the hypothalamic-pituitarytesticular axis in men with idiopathic oligozoospermia. Fertil Steril 2009; 91: 1427-1430.
2. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR: Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial. Multiple outcomes of raloxifene evaluation (more) investigators. Jama 1999; 282: 637-645. (Pubitemid 29384151)
3. Cummings SR, Eckert S, Krueger KA, Grady D, Powles TJ, Cauley JA, Norton L, Nickelsen T, Bjarnason NH, Morrow M, Lippman ME, Black D, Glusman JE, Costa A, Jordan VC: The effect of raloxifene on risk of breast cancer in postmenopausal women: Results from the more randomized trial. Multiple outcomes of raloxifene evaluation. Jama 1999; 281: 2189-2197. (Pubitemid 29275701)
4. Fuchs-Young R, Glasebrook AL, Short LL, Draper MW, Rippy MK, Cole HW, Magee DE, Termine JD, Bryant HU: Raloxifene is a tissue-selective agonist/antagonist that functions through the estrogen receptor. Ann N Y Acad Sci 1995; 761: 355-360.
5. Benoff S, Chu CC, Marmar JL, Sokol RZ, Goodwin LO, Hurley IR: Voltage-dependent calcium channels in mammalian spermatozoa revisited. Front Biosci 2007; 12: 1420-1449. (Pubitemid 46846844)
6. Darszon A, Lopez-Martinez P, Acevedo JJ, Hernandez-Cruz A, Trevino CL: T-type Ca 2+ channels in sperm function. Cell Calcium 2006; 40: 241-252.
7. Park JY, Ahn HJ, Gu JG, Lee KH, Kim JS, Kang HW, Lee JH: Molecular identification of Ca 2+ channels in human sperm. Exp Mol Med 2003; 35: 285-292.
8. Darszon A, Nishigaki T, Wood C, Trevino CL, Felix R, Beltran C: Calcium channels and Ca 2+ fluctuations in sperm physiology. Int Rev Cytol 2005; 243: 79-172. (Pubitemid 41557299)
9. Tao J, Zhang Y, Li S, Sun W, Soong TW: Tyrosine kinase-independent inhibition by genistein on spermatogenic t-type calcium channels attenuates mouse sperm motility and acrosome reaction. Cell Calcium 2009; 45: 133-143.
10. Espinosa F, Lopez-Gonzalez I, Serrano CJ, Gasque G, de la Vega-Beltran JL, Trevino CL, Darszon A: Anion channel blockers differentially affect t-type Ca(2+) currents of mouse spermatogenic cells, alpha1e currents expressed in xenopus oocytes and the sperm acrosome reaction. Dev Genet 1999; 25: 103-114. (Pubitemid 29407192)
11. Espinosa F, Lopez-Gonzalez I, Munoz-Garay C, Felix R, De la Vega-Beltran JL, Kopf GS, Visconti PE, Darszon A: Dual regulation of the t-type Ca(2+) current by serum albumin and beta-estradiol in mammalian spermatogenic cells. FEBS Lett 2000; 475: 251-256. (Pubitemid 30408463)
12. Baldi E, Luconi M, Muratori M, Forti G: A novel functional estrogen receptor on human sperm membrane interferes with progesterone effects. Mol Cell Endocrinol 2000; 161: 31-35. (Pubitemid 30201647)
13. Ullrich ND, Krust A, Collins P, MacLeod KT: Genomic deletion of estrogen receptors eralpha and erbeta does not alter estrogenmediated inhibition of Ca 2+ influx and contraction in murine cardiomyocytes. Am J Physiol Heart Circ Physiol 2008; 294:H2421-H2427.
14. Liew R, Stagg MA, MacLeod KT, Collins P: Raloxifene acutely suppresses ventricular myocyte contractility through inhibition of the l-type calcium current. Br J Pharmacol 2004; 142: 89-96. (Pubitemid 38698197)
15. Xiao H, Zhang XC, Zhang L, Dai XQ, Gong W, Cheng J, Gao R, Wang X: Fenvalerate modifies t-type Ca 2+ channels in mouse spermatogenic cells. Reprod Toxicol 2006; 21: 48-53. (Pubitemid 43048774)
16. Santi CM, Darszon A, Hernandez-Cruz A: A dihydropyridine-sensitive t-type Ca 2+ current is the main Ca 2+ current carrier in mouse primary spermatocytes. Am J Physiol 1996; 271:C1583-C1593.
17. 1996; 55: 923-932. (Pubitemid 26304773)
18. Bai J, Shi Y: Inhibition of t-type Ca(2+) currents in mouse spermatogenic cells by gossypol, an antifertility compound. Eur J Pharmacol 2002; 440: 1-6. (Pubitemid 34312032)
19. Lu L, Wang C, Gao X, Xu P, Wang J, Wang Q, Cheng J, Xiao H: Effects of copper on t-type Ca 2+ channels in mouse spermatogenic cells. J Membr Biol 2009; 227: 87-94.
20. Cataldi M, Lariccia V, Marzaioli V, Cavaccini A, Curia G, Viggiano D, Canzoniero LM, di Renzo G, Avoli M, Annunziato L: Zn(2+) slows down Ca(v)3.3 gating kinetics: Implications for thalamocortical activity. J Neurophysiol 2007; 98: 2274-2284. (Pubitemid 47584412)
21. Neubauer BL, Best KL, Clemens JA, Gates CA, Goode RL, Jones CD, Laughlin ME, Shaar CJ, Toomey RE, Hoover DM: Endocrine and antiprostatic effects of raloxifene (ly156758) in the male rat. Prostate 1993; 23: 245-262. (Pubitemid 24001297)
22. Couse JF, Korach KS: Estrogen receptor null mice: What have we learned and where will they lead us? Endocr Rev 1999; 20: 358-417. (Pubitemid 30654784)
23. Solakidi S, Psarra AM, Nikolaropoulos S, Sekeris CE: Estrogen receptors alpha and beta (eralpha and erbeta) and androgen receptor (ar) in human sperm: Localization of erbeta and ar in mitochondria of the midpiece. Hum Reprod 2005; 20: 3481-3487. (Pubitemid 41742531)
24. Zhou Q, Nie R, Prins GS, Saunders PT, Katzenellenbogen BS, Hess RA: Localization of androgen and estrogen receptors in adult male mouse reproductive tract. J Androl 2002; 23: 870-881. (Pubitemid 36300978)
25. 2007; 147: 334-341. (Pubitemid 46907448)
26. Coiret G, Matifat F, Hague F, Ouadid-Ahidouch H: 17-beta-estradiol activates maxi-k channels through a non-genomic pathway in human breast cancer cells. FEBS Lett 2005; 579: 2995-3000. (Pubitemid 40797825)
27. Guo RX, Wei LH, Tu Z, Sun PM, Wang JL, Zhao D, Li XP, Tang JM: 17 beta-estradiol activates pi3k/akt signaling pathway by estrogen receptor (er)-dependent and er-independent mechanisms in endometrial cancer cells. J Steroid Biochem Mol Biol 2006; 99: 9-18. (Pubitemid 44382541)
28. 2001; 413: 603-609. (Pubitemid 32964054)
29. Zhang D, Chen J, Saraf A, Cassar S, Han P, Rogers JC, Brioni JD, Sullivan JP, Gopalakrishnan M: Association of catsper1 or -2 with Ca(v)3.3 leads to suppression of t-type calcium channel activity. J Biol Chem 2006; 281: 22332-22341. (Pubitemid 44181935)
30. Trevino CL, Felix R, Castellano LE, Gutierrez C, Rodriguez D, Pacheco J, Lopez-Gonzalez I, Gomora JC, Tsutsumi V, Hernandez- Cruz A, Fiordelisio T, Scaling AL, Darszon A: Expression and differential cell distribution of low-threshold Ca(2+) channels in mammalian male germ cells and sperm. FEBS Lett 2004; 563: 87-92. (Pubitemid 38471579)
31. 2. Journal of Andrology 2008; 3: 293-303.
32. Marni F, Wang Y, Morishima M, Shimaoka T, Uchino T, Zheng M, Kaku T, Ono K: 17 beta-estradiol modulates expression of lowvoltage- activated Ca(v)3.2 t-type calcium channel via extracellularly regulated kinase pathway in cardiomyocytes. Endocrinology 2009; 150: 879-888.